Avantor, Inc. (AVTR)
- Sector
- Life Sciences Tools & Services
- Last price
- $16.69
- As of
Kresmion compiles this page from AVTR's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Avantor, Inc. (AVTR): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-10-28.
See the full AVTR dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for AVTR on one page. Preview it with sample data, then open it live with a free account.
Preview the AVTR dossierActive events for AVTR
- high13F: large reduction
CITADEL ADVISORS LLC cut 81% of AVTR (2026Q2)
- high13F: large reduction
CITADEL ADVISORS LLC cut 88% of AVTR (2026Q2)
- high13F: large increase
MILLENNIUM MANAGEMENT LLC added +654% to AVTR (2026Q2)
- high13F: large increase
Bridgewater Associates, LP added +135% to AVTR (2026Q2)
- mediumEarnings above estimates
Q2-2026: Beat consensus by 8.6%, EPS $0.21 vs $0.1934 estimate
FREE, NO ACCOUNT
Every event on AVTR, as it fires
You are seeing 5 of 10 events recorded on AVTR since 2026-05-26.
The five above landed across 2 days. The other 5 were recorded on 2 other days. 7 of the 10 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in AVTR (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| GREENHAVEN ASSOCIATES INCCUSIP 05352A100 · 2026Q2 | $243.9M | 2.82% | , |
| D. E. Shaw & Co., Inc.CUSIP 05352A100 · 2026Q2 | $94.8M | 0.05% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 05352A100 · 2026Q2 | $7.5M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 05352A100 · 2026Q2 | $4M | 0.00% | , |
| Bridgewater Associates, LPCUSIP 05352A100 · 2026Q2 | $3M | 0.01% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, AVTR
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
AVTR against its peers
AVTR's operating margin of -3.8% ranks in the 48th percentile of 23 Life Sciences Tools & Services sub-industry peers, fiscal periods ending between 2025-10-31 and 2026-06-30.
| Metric | AVTR | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 6.6B USD | 1.2B USD | 83 | 25 |
| Gross margin | 32.7% | 59.1% | 16 | 15 |
| Operating margin | -3.8% | 0.6% | 48 | 23 |
| Net margin | -8.1% | -0.3% | 40 | 25 |
| Return on equity | -9.5% | -2.5% | 42 | 24 |
| P / E | n/a | 45.8x | n/a | 12 |
| 1 year | n/a | 26.3% | n/a | 7 |
Peers (25): TECH, TXG, RGEN, BRKR, TEM, CRL, MEDP, SHC, ADPT, ABCL, MTD, ILMN, IQV, WAT, A, FTRE, MRVI, DHR, CTKB, MLAB, OABI, DNA, PACB, TMO, MXCT. Fiscal periods ending between 2025-10-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (AVTR: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow AVTR on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to AVTR for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.